Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1994 5
1995 6
1996 17
1997 59
1998 60
1999 63
2000 49
2001 62
2002 61
2003 71
2004 61
2005 59
2006 59
2007 52
2008 64
2009 61
2010 61
2011 55
2012 63
2013 47
2014 65
2015 80
2016 83
2017 62
2018 56
2019 41
2020 58
2021 43
2022 46
2023 41
2024 14

Text availability

Article attribute

Article type

Publication date

Search Results

1,491 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for lispro
Your search for lisiprol retrieved no results
Tirzepatide vs Insulin Lispro Added to Basal Insulin in Type 2 Diabetes: The SURPASS-6 Randomized Clinical Trial.
Rosenstock J, Frías JP, Rodbard HW, Tofé S, Sears E, Huh R, Fernández Landó L, Patel H. Rosenstock J, et al. JAMA. 2023 Nov 7;330(17):1631-1640. doi: 10.1001/jama.2023.20294. JAMA. 2023. PMID: 37786396 Free PMC article. Clinical Trial.
INTERVENTIONS: Participants were randomized (in a 1:1:1:3 ratio) to receive once-weekly subcutaneous injections of tirzepatide (5 mg [n = 243], 10 mg [n = 238], or 15 mg [n = 236]) or prandial thrice-daily insulin lispro (n = 708). MAIN OUTCOMES AND MEASURES: Outcom …
INTERVENTIONS: Participants were randomized (in a 1:1:1:3 ratio) to receive once-weekly subcutaneous injections of tirzepatide (5 mg [n = 24 …
[Ultra-rapid lispro (Lyumjev)].
Philips JC, Paquot N. Philips JC, et al. Rev Med Liege. 2021 Jan;76(1):64-68. Rev Med Liege. 2021. PMID: 33443332 Free article. Review. French.
Development of new insulins aims to mimic in a better way the natural physiology of this hormone secreted by the pancreas. Rapid insulin analogues have proven a better capacity to reduce postprandial glycaemic peaks after eating. ...Ultra-rapid lispro (URLi) Lyumjev …
Development of new insulins aims to mimic in a better way the natural physiology of this hormone secreted by the pancreas. Rapid insulin …
Insulin lispro.
Holleman F, Hoekstra JB. Holleman F, et al. N Engl J Med. 1997 Jul 17;337(3):176-83. doi: 10.1056/NEJM199707173370307. N Engl J Med. 1997. PMID: 9219705 Review. No abstract available.
Insulin and Lispro Insulin: What is Common and Different in their Behavior?
Selivanova OM, Suvorina MY, Surin AK, Dovidchenko NV, Galzitskaya OV. Selivanova OM, et al. Curr Protein Pept Sci. 2017;18(1):57-64. doi: 10.2174/1389203717666160526122421. Curr Protein Pept Sci. 2017. PMID: 27226198 Review.
For the study we have chosen one of the insulin analogues - insulin Lispro, which is a fast acting insulin analog. ...We have estimated the size of the primary nucleus to be one monomer and the size of the secondary nucleus to be around zero in both …
For the study we have chosen one of the insulin analogues - insulin Lispro, which is a fast acting insulin analo …
What is the value of faster acting prandial insulin? Focus on ultra rapid lispro.
Heise T, Piras de Oliveira C, Juneja R, Ribeiro A, Chigutsa F, Blevins T. Heise T, et al. Diabetes Obes Metab. 2022 Sep;24(9):1689-1701. doi: 10.1111/dom.14773. Epub 2022 Jun 15. Diabetes Obes Metab. 2022. PMID: 35593434 Free PMC article. Review.
Increased demand for faster acting insulins, which can quickly control PPG excursions without increasing the risk of late hypoglycaemia, led to the development of ultra-rapid-acting insulins, including ultra-rapid lispro (URLi). URLi is a novel formulation of insulin …
Increased demand for faster acting insulins, which can quickly control PPG excursions without increasing the risk of late hypoglycaemia, led …
20 Years of insulin lispro in pediatric type 1 diabetes: a review of available evidence.
Kaiserman K, Jung H, Benabbad I, Karges B, Polak M, Rosilio M. Kaiserman K, et al. Pediatr Diabetes. 2017 Mar;18(2):81-94. doi: 10.1111/pedi.12401. Epub 2016 Jul 8. Pediatr Diabetes. 2017. PMID: 27390032 Review.
BACKGROUND: Insulin lispro, the first rapid-acting insulin analog, was developed 20 years ago and has been studied in multiple situations and various populations. ...Continuous subcutaneous insulin infusion (CSII)-treatment with insulin lispr …
BACKGROUND: Insulin lispro, the first rapid-acting insulin analog, was developed 20 years ago and has been studied in m …
Subcutaneous rapid-acting insulin analogues for diabetic ketoacidosis.
Andrade-Castellanos CA, Colunga-Lozano LE, Delgado-Figueroa N, Gonzalez-Padilla DA. Andrade-Castellanos CA, et al. Cochrane Database Syst Rev. 2016 Jan 21;2016(1):CD011281. doi: 10.1002/14651858.CD011281.pub2. Cochrane Database Syst Rev. 2016. PMID: 26798030 Free PMC article. Review.
Socioeconomic effects as measured by length of mean hospital stay for insulin lispro compared with regular insulin showed a MD of -0.4 days (95% CI -1 to 0.2); P = 0.22; 90 participants; 2 trials; low-quality evidence and for insulin aspart compared wi …
Socioeconomic effects as measured by length of mean hospital stay for insulin lispro compared with regular insulin show …
Use of Insulin Lispro Protamine Suspension in Pregnancy.
Lapolla A, Dalfrà MG, Romoli E, Bonomo M, Moghetti P. Lapolla A, et al. Adv Ther. 2015 Oct;32(10):888-905. doi: 10.1007/s12325-015-0244-y. Epub 2015 Oct 26. Adv Ther. 2015. PMID: 26499176 Free PMC article. Review.
As the binding of insulin lispro is unaffected by the protamine molecule, ILPS is likely to have the same mitogenic and immunogenic potential as insulin lispro. Insulin lispro produces similar outcomes to regular insulin in pregnan …
As the binding of insulin lispro is unaffected by the protamine molecule, ILPS is likely to have the same mitogenic and immuno …
Insulin lispro update.
Meece JD, Campbell RK. Meece JD, et al. Diabetes Educ. 2002 Mar-Apr;28(2):269-77. doi: 10.1177/014572170202800212. Diabetes Educ. 2002. PMID: 11924304
PURPOSE: This paper provides a review of the literature and clinical studies for insulin lispro and updated information on its advantages over regular insulin for various populations of people with diabetes. METHODS: Information was gathered from a search of …
PURPOSE: This paper provides a review of the literature and clinical studies for insulin lispro and updated information on its …
Insulin lispro protamine suspension in the treatment of patients with type 1 and type 2 diabetes mellitus: a systematic review of published data.
Ceriello A, Cremasco F, Romoli E, Rossi A, Gentilella R. Ceriello A, et al. Expert Opin Pharmacother. 2012 Feb;13(2):255-81. doi: 10.1517/14656566.2012.650862. Epub 2012 Jan 13. Expert Opin Pharmacother. 2012. PMID: 22242803 Review.
INTRODUCTION: Insulin lispro protamine suspension (ILPS) is a protamine-based insulin lispro formulation that allows 24-h coverage while limiting the number of daily injections. ILPS was developed to be the basal insulin component of premixed bi …
INTRODUCTION: Insulin lispro protamine suspension (ILPS) is a protamine-based insulin lispro formulation that al …
1,491 results